Article
Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer.
Scientific reports - 24 Feb 2015
Huang Chao-Yuan, Huang Shu-Pin, Lin Victor C, Yu Chia-Cheng, Chang Ta-Yuan, Juang Shin-Hun, Bao Bo-Ying
Abstract excerpt
While localized prostate cancer is potentially curative, many patients still show biochemical recurrence (BCR) after curative treatments such as radical prostatectomy (RP). The Hippo pathway has recently been shown to be an evolutionarily conserved regulator of tissue growth, and its perturbation can trigger tumorigenesis. We hypothesize that genetic variants of the Hippo pathway may influence clinical outcomes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
